Lanua Medical Ltd. raised €6 million (US$6.3 million) in seed funding for its Encore device, which is designed to enhance embolization procedures. The funds will be used to accelerate the development of the technology as well as expand operations into the U.S. The funding round was co-led by Elkstone and Atlantic Bridge, with participation from Enterprise Ireland and Furthr VC.